Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma

D. V.T. Catenacci, H. C. Chung, L. Shen, M. Moehler, H. H. Yoon, M. K. Rosales, Y. K. Kang

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences